SCHEDULE 13G

Company

Can-Fite BioPharma Ltd.

Filed

December 5, 2014

Accession Number

0000902664-14-004522

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →